Advanced Biomed ADVB
NASDAQ ADVB
$6.73 -0.30 (-4.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Advanced Biomed (ADVB) Liabilities from Discontinued Operations (2025)

Updated

Advanced Biomed's Liabilities from Discontinued Operations was $69,797 in fiscal Q4 2025 (quarter ended Jun 30, 2025).

Analysis

Advanced Biomed (ADVB) Liabilities from Discontinued Operations (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn
10 Advanced Biomed 9.72 Mn 9.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 69,797.00
API Access

Advanced Biomed Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=ADVB&period=max&api_key=YOUR_API_KEY